Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
Nature Medicine
|
February 8, 2013
RNA editing enters the limelight in cancer
Angela Gallo
Biological Reviews of the Cambridge Philosophical Society
|
June 21, 2011
ADARs: allies or enemies? The importance of A-to-I RNA editing in human disease: from cancer to HIV-1
Angela Gallo, Franco Locatelli
RNA Biology
|
September 2, 2008
A-to-I RNA editing and cancer: from pathology to basic science
Angela Gallo, Silvia Galardi
Frontiers in Microbiology
|
May 10, 2017
The Role of HCMV and HIV-1 MicroRNAs: Processing, and Mechanisms of Action during Viral Infection
Doriana Fruci, Rossella Rota, Angela Gallo
Cell and Tissue Research
|
April 29, 2014
The RNA editing enzymes ADARs: mechanism of action and human disease
Sara Tomaselli, Franco Locatelli, Angela Gallo
Hepatology (Baltimore, Md.)
|
May 13, 2011
Hepatitis C virus therapeutics: editing enzymes promising therapeutic targets?
Anna Alisi, Sara Tomaselli, Clara Balsano, et al.
Biomarkers in Medicine
|
December 12, 2012
Circulating miRNA profiling to identify biomarkers of dysmetabolism
Sara Tomaselli, Nadia Panera, Angela Gallo, et al.
Seminars in Cell & Developmental Biology
|
September 21, 2011
A-to-I RNA editing: the "ADAR" side of human cancer
Federica Galeano, Sara Tomaselli, Franco Locatelli, et al.
Current Issues in Molecular Biology
|
December 16, 2014
ADARs and the Balance Game between Virus Infection and Innate Immune Cell Response
Sara Tomaselli, Federica Galeano, Franco Locatelli, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
January 12, 2015
Detection of post-transcriptional RNA editing events
Ernesto Picardi, Anna Maria D'Erchia, Angela Gallo, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
Nature Medicine
|
February 8, 2013
RNA editing enters the limelight in cancer
Angela Gallo
Biological Reviews of the Cambridge Philosophical Society
|
June 21, 2011
ADARs: allies or enemies? The importance of A-to-I RNA editing in human disease: from cancer to HIV-1
Angela Gallo, Franco Locatelli
RNA Biology
|
September 2, 2008
A-to-I RNA editing and cancer: from pathology to basic science
Angela Gallo, Silvia Galardi
Frontiers in Microbiology
|
May 10, 2017
The Role of HCMV and HIV-1 MicroRNAs: Processing, and Mechanisms of Action during Viral Infection
Doriana Fruci, Rossella Rota, Angela Gallo
Cell and Tissue Research
|
April 29, 2014
The RNA editing enzymes ADARs: mechanism of action and human disease
Sara Tomaselli, Franco Locatelli, Angela Gallo
Hepatology (Baltimore, Md.)
|
May 13, 2011
Hepatitis C virus therapeutics: editing enzymes promising therapeutic targets?
Anna Alisi, Sara Tomaselli, Clara Balsano, et al.
Biomarkers in Medicine
|
December 12, 2012
Circulating miRNA profiling to identify biomarkers of dysmetabolism
Sara Tomaselli, Nadia Panera, Angela Gallo, et al.
Seminars in Cell & Developmental Biology
|
September 21, 2011
A-to-I RNA editing: the "ADAR" side of human cancer
Federica Galeano, Sara Tomaselli, Franco Locatelli, et al.
Current Issues in Molecular Biology
|
December 16, 2014
ADARs and the Balance Game between Virus Infection and Innate Immune Cell Response
Sara Tomaselli, Federica Galeano, Franco Locatelli, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
January 12, 2015
Detection of post-transcriptional RNA editing events
Ernesto Picardi, Anna Maria D'Erchia, Angela Gallo, et al.
Page
of 6